MTCO2P3

Across TCGA pan-cancer cohorts, MTCO2P3 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated MTCO2P3 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher MTCO2P3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTCO2P3 expression acts as an unfavorable survival marker.

COAD, THCA, and GBM are the cancer types where MTCO2P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	All	0.039	0.871	<.001	108	view →
THCA	DFS	Tertile	All	0.062	0.811	<.001	45	view →
GBM	OS	Tertile	All	0.026	0.416	<.001	36	view →
BRCA	DFS	Tertile	All	0.115	0.527	.001	24	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

MTCO2P3–COAD (OS)

Open the COAD breakdown →